Pilot Award Recipient: Hemayet Ullah, PhD
The proposed project is evaluating the potential of a new investigative drug to inhibit HIV-1 proliferation in cells.
The DC CFAR has funded a wide variety of research, including basic, clinical, epidemiologic, social behavioral and prevention HIV/AIDS science since 2017.
Pilot Award Recipient: Hemayet Ullah, PhD
The proposed project is evaluating the potential of a new investigative drug to inhibit HIV-1 proliferation in cells.
Pilot Award Recipient: Elanah Uretsky, PhD
This one year pilot study will assess and describe risk behavior for HIV among African migrants living in Guangzhou, China.
Pilot Award Recipient: Kirsten Stoebenau, PhD
Studies have shown that girls and young women in sub-Saharan Africa who report having had relationships with men based on an expectation that the man will support them financially and they will...
Pilot Award Recipient: Rebecca Lynch, PhD
Vaccines are currently being designed to elicit effective, neutralizing antibody responses that will protect against HIV infection.
Pilot Award Recipient: Sarah Baird, PhD, MS
In 2013, UNAIDS estimated that globally, 2.1 million adolescents (age 10-19 years) were living with HIV.
Pilot Award Recipient: Sherry Molock, PhD
African Americans constitute 12% of the population in the U.S., but 44% of HIV cases and the highest number of new infections.
Pilot Award Recipient: John Hawdon, PhD
HIV infection remains a major cause of mortality and morbidity despite advances in treatment and prevention.
Pilot Award Recipient: Dominic Proulx, PhD
HIV infection leads to the development of chronic inflammation that persists even in antiretroviral-treated individuals with undetectable viral loads.
Pilot Award Recipient: R. Brad Jones, PhD
The development of a safe and effective cure for HIV is hampered by the lack of a predictive small animal model that could be used to test and optimize new therapies.
Pilot Award Recipient: Shawnika Hull, PhD
In the District of Columbia, Black women are 50% of females, 1 but they account for 92% of women living with HIV.